To further understand how rVP1 could reduce expression of COX-2, we next examined whether ILK or the IKK/NF-κB pathway plays any role in the inhibitory effect of rVP1 on COX-2 expression in lung cancer cells. Here, NFKB1 is linked to lung carcinoma.